Back

Disease Comparison

Compare similarities and differences between two diseases.

Antiphospholipid Syndrome

Unknown
2
Symptoms
3
Causes
0
Treatments
5
FAQs
VS

Premenstrual Dysphoric Disorder

Moderate
4
Symptoms
1
Causes
0
Treatments
5
FAQs

Overview

Antiphospholipid Syndrome
Antiphospholipid syndrome is an autoimmune disorder in which persistent antiphospholipid antibodies increase the tendency of the blood to clot abnormally. The condition can cause blood clots in veins or arteries and is also associated with certain pregnancy complications. Clots may affect the legs, lungs, brain, or other organs. Some people have antiphospholipid antibodies without developing clinical complications, so diagnosis requires both appropriate clinical findings and persistent laboratory evidence.
Premenstrual Dysphoric Disorder
Premenstrual dysphoric disorder (PMDD) is a severe cyclical condition in which emotional, behavioral, and physical symptoms occur during the premenstrual phase and substantially interfere with daily functioning, relationships, work, or other activities. Symptoms typically improve after menstruation begins. PMDD is more severe than typical premenstrual symptoms and commonly includes marked mood changes, irritability, depression, anxiety, difficulty concentrating, fatigue, sleep changes, and physical symptoms.

Symptoms

Shared
None
Only in Left Disease
Brittle Nails Difficulty Healing
Only in Right Disease
Depressed Mood Irritability Itching Mood Swings

Causes

Shared
None
Only in Left Disease
Autoimmune Disorder Genetics Pregnancy
Only in Right Disease
Hormonal Imbalance

Diagnosis

Antiphospholipid Syndrome
Diagnosis requires appropriate clinical findings together with persistent laboratory evidence of antiphospholipid antibodies. Relevant clinical findings include objectively confirmed thrombosis or specific pregnancy complications recognized as part of the syndrome. Laboratory evaluation may test for lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. Positive antibody findings generally need to remain present on repeat testing performed at the appropriate interval rather than being based on a single isolated result.
Premenstrual Dysphoric Disorder
Diagnosis is based on the timing, number, severity, and cyclical recurrence of symptoms across menstrual cycles and the degree to which they interfere with daily functioning. Prospective symptom tracking over multiple cycles is often used to document the pattern. Evaluation also considers other psychiatric, medical, and gynecological conditions that can cause similar symptoms. There is no single blood test that confirms PMDD.

Prevention

Antiphospholipid Syndrome
Risk reduction depends on the person's history and whether antiphospholipid syndrome has already caused thrombosis or pregnancy complications. Avoiding smoking, maintaining regular movement, managing blood pressure and other cardiovascular risk factors, and following prescribed preventive treatment can reduce clotting risk. During periods of increased risk such as surgery, prolonged immobility, or pregnancy, medical advice should be followed carefully. People with confirmed antiphospholipid syndrome may require individualized anticoagulation or pregnancy-related management.
Premenstrual Dysphoric Disorder
There is no guaranteed way to prevent PMDD because it is associated with individual sensitivity to normal hormonal fluctuations. Regular sleep, physical activity, balanced nutrition, and effective stress management may help reduce the impact of symptoms. Tracking menstrual cycles and symptoms can help identify patterns and support early assessment when emotional or physical symptoms repeatedly interfere with work, relationships, or other daily activities.

Risk Factors

Antiphospholipid Syndrome
Risk is influenced by persistent antiphospholipid antibodies, a previous blood clot, pregnancy-related complications, and associated autoimmune disease such as systemic lupus erythematosus. Additional factors such as smoking, prolonged immobility, surgery, estrogen exposure, and other inherited or acquired clotting risks can further increase the likelihood of thrombosis. The overall risk varies considerably between individuals.
Premenstrual Dysphoric Disorder
Risk may be increased by a personal or family history of mood disorders, previous significant premenstrual symptoms, and individual sensitivity to normal reproductive hormone changes. Some people may also have coexisting anxiety or depressive disorders. PMDD occurs in people who are biologically sensitive to cyclical hormonal changes, and symptoms may vary over different stages of reproductive life.

Treatment

Antiphospholipid Syndrome
Treatment comparison will be available soon.
Premenstrual Dysphoric Disorder
Treatment comparison will be available soon.